Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 03 2024
0mins
Source: Newsfilter
Merger Announcement: Reneo Pharmaceuticals and OnKure, Inc. are set to merge, with the combined company to be named OnKure Therapeutics, Inc., trading on Nasdaq under the ticker "OKUR" starting October 7, 2024.
Stock Split Details: Reneo will implement a 1-for-10 reverse stock split prior to the merger, adjusting outstanding shares while ensuring no fractional shares are issued, and maintaining the same number of authorized shares.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
